Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

Delayed Quote. Delayed  - 05/27 09:59:58 pm
89.09 USD   +2.10%
05/25DJSAREPTA : FDA's Decision on Dystrophy Drug Delayed
05/16 ABSCI : Appoints Daniel Gold, Ph.D. to Board of Directors
05/05 NASDAQ 100 MOVE : Bmrn, disca
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical In
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.

It operates its business through one segment, the biopharmaceutical development and commercialization segment.

Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded on March 21, 1997 and is headquartered in Novato, CA.

Number of employees : 2 158 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Biopharmaceutical Development and Commercialization751.04100.1%889.90102% +18.49%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States380.0450.7%444.0850.9% +16.85%
Europe139.9418.7%178.7520.5% +27.73%
Latin America118.5615.8%142.3116.3% +20.03%
Rest of World112.4915%124.7714.3% +10.91%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé622005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA572012Chief Financial Officer & Executive Vice President
Henry J. Fuchs, MD582009Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Pierre LaPalme752004Director
Elaine J. Heron PhD, MBA682002Independent Non-Executive Director
Mike G. Grey632005Independent Non-Executive Director
Richard A. Meier562006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD642007Independent Non-Executive Director
Alan J. Lewis, PhD702005Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 162,322,439 161,949,590 99.8% 0 0.0% 99.8%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 15,853,295 9.77%
Fidelity Management & Research Co. 12,075,277 7.44%
Sands Capital Management LLC 11,561,504 7.12%
The Vanguard Group, Inc. 11,102,321 6.84%
Jennison Associates LLC 8,749,891 5.39%
BlackRock Fund Advisors 7,492,849 4.62%
PRIMECAP Management Co. 7,350,369 4.53%
T. Rowe Price Associates, Inc. 6,218,760 3.83%
Baker Bros. Advisors LP 4,806,483 2.96%
JPMorgan Investment Management, Inc. 3,626,082 2.23%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6678.04%4,533,334 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Generic Pharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
SUN PHARMACEUTICA..
ONO PHARMACEUTICA..
OTSUKA HOLDINGS C..
BIOMARIN PHARMACE..
ASPEN PHARMACARE ..
TAISHO PHARMACEUT..
HANMI SCIENCE CO ..
-
SHANGHAI FOSUN PH..
CIPLA LTD
HANMIPHARM
CADILA HEALTHCARE..
HUNAN ER-KANG PHA..
DIVI'S LABORATORI..
SHENZHEN SALUBRIS..
JIANGSU BICON PHA..
RICHTER GEDEON VE..
GLENMARK PHARMACE..
CHINA MEDICAL SYS..
ENDO INTERNATIONA..
STADA ARZNEIMITTE..
Sector Pharmaceuticals
BioMarin Pharmaceutical In : Connections
Targazyme, Inc.
Algorithme Pharma, Inc.
Zephyrus Biosciences, Inc.
DiaVacs, Inc.
AbSci LLC
Amplyx Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc.
Cellastra, Inc.
Ziarco Group Ltd.
Rincon Pharmaceuticals, Inc.
GLyPharma Therapeutic, Inc.
Pediapharm Inc
GlycoFi, Inc.
Reform Biologics LLC
Ziarco Pharma Ltd.
Selventa, Inc.
Rapidscan Pharma Solutions, Inc.
Sutro Biopharma, Inc.
Balance Therapeutics, Inc.
Cytochroma, Inc.
A. M. Pappas & Associates LLC
Batu Biologics, Inc.
Biotechnology Industry Organization
Sosei Co. Ltd.
Aerogen, Inc.
Itero Biopharmaceuticals LLC
Capella Therapeutics, Inc.
Company contact information
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415-506-6700
Fax : +1 415-382-7889
Internet : http://www.bmrn.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- ISIN Code :  US09061G1013
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem